New rule makes it harder for patients to lower their out-of-pocket costs

In the midst of increased financial insecurity for Americans due to the COVID-19 pandemic, it is shocking the Administration finalized a policy change in the 2021 Notice of Benefit and Payment Parameters allowing insurers and pharmacy benefit managers (PBMs) to make it harder for patients to have manufacturer cost-sharing assistance count towards their out-of-pocket caps for medicines.
Source: The Catalyst - Category: Pharmaceuticals Tags: Drug Cost Out-of-Pocket Costs Let's Talk About Cost Source Type: news